Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.

Goto K, Hayashi H, Maruti SS, Zettl H, Mittal L, Pathak S, Le X

Open source

DOI
10.1007/s11523-026-01213-4
Published
2026 May
Container
Targeted oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11523-026-01213-4,
  title = {Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.},
  author = {Goto K and Hayashi H and Maruti SS and Zettl H and Mittal L and Pathak S and Le X},
  year = {2026},
  journal = {Targeted oncology},
  doi = {10.1007/s11523-026-01213-4},
  url = {https://doi.org/10.1007/s11523-026-01213-4}
}

RIS

TY  - JOUR
TI  - Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.
AU  - Goto K
AU  - Hayashi H
AU  - Maruti SS
AU  - Zettl H
AU  - Mittal L
AU  - Pathak S
AU  - Le X
PY  - 2026
JO  - Targeted oncology
DO  - 10.1007/s11523-026-01213-4
UR  - https://doi.org/10.1007/s11523-026-01213-4
ER  - 

APA

K, G., H, H., SS, M., H, Z., L, M., S, P., & X, L. (2026). Epidemiology and Real-World Outcomes in Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Mutant Non-small Cell Lung Cancer by Region: A Targeted Literature Review.. Targeted oncology. https://doi.org/10.1007/s11523-026-01213-4

Source records